Wedbush Forecasts Increased Earnings for Avalo Therapeutics
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Free Report) – Wedbush raised their Q2 2025 earnings per share estimates for shares of Avalo Therapeutics in a research note issued to investors on Thursday, March 20th. Wedbush analyst R. Driscoll now expects that the company will post earnings of ($1.25) per share for the quarter, up from their […]
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Free Report) – Wedbush raised their Q2 2025 earnings per share estimates for shares of Avalo Therapeutics in a research note issued to investors on Thursday, March 20th. Wedbush analyst R. Driscoll now expects that the company will post earnings of ($1.25) per share for the quarter, up from their […]
